List of Webinars 2024

22 February 2024 at 12 pm GMT; Duration 1 hour

Register here

To check the corresponding time in your country please check this link:

Update: 1 CPD/CME point is applied to this event. 

Organizer: John Damilakis
Moderator: John Damilakis & Magdalena Stoeva

Title: Patient Radiation Safety: Meet the IOMP Corporate Members


Delena Hanson, LAP America

Greg Martin, SUN Nuclear

Title 1: LUNA 3D – The New More in Surface Guided Radiation Therapy by LAP

Speaker: Delena Hanson, MSRT, RTT, CSPO, PMP, Director of Clinical Implementation, LAP of America

Delena Hanson is the Director of Clinical Implementation for LAP Laser in the US.  She has specialized in SGRT for the past decade, moving from clinical user to applications trainer to senior product manager. Delena is currently leading the education and application of the new LUNA 3D SGRT system from LAP for North America. Delena is inspired by the patients and families she meets and the clinicians caring for them. She is passionate about helping cancer patients live better lives.


LAP is one of the world’s leading systems suppliers that increase the quality and efficiency of radiation therapy. LAP provides laser systems offering precise patient alignment and marking at CTs, MRIs, and LINACs. LAP phantoms and RadCalc, the patient-centric 3D QA software, streamline tasks for medical physicists throughout the patient’s journey. At ASTRO 2023, LAP launched the new LUNA 3D SGRT system, supporting reproducible patient positioning and monitoring patient surface motion at LINACs and CTs. LUNA 3D streamlines workflows with a browser-based interface across multiple screens and features a virtual laser for swift patient setup. The system supports ergonomic patient setup, utilizing high-resolution stereoscopic CMOS cameras with GPU-powered calculations for accuracy and low latency. LUNA 3D engages patients through a coaching screen, facilitating precise dose delivery. Multiple regions of interest (ROIs) enable focused treatment on different surface regions during setup and therapy.

Title 2: Sun Nuclear: Your Trusted Partner for Patient Safety

Speaker: Greg Martin, MSc.

Registered clinical scientist in the UK, with 5 years clinical experience working in a 10 linac, NHS radiotherapy center, UK.  Honorary Lecturer. Number of poster publications at international conferences including AAPM and ESTRO.


Sun Nuclear has been delivering independent quality assurance to the radiation treatment industry for 40 years. Our customers and partners are the guardians of patient safety. They rely on our innovative and efficient solutions at over 5,000 facilities around the world. In this presentation you will learn where Sun Nuclear has been and where we are going along with insights into a few of our key products highlighting how they reduce risk, control costs and improve treatment quality.

8 March 2024 at 12 pm GMT; Duration 1 hour

Register here

To check the corresponding time in your country please check this link:

Update: 1 CPD/CME point is applied to this event. 

Organizer: Loredana Marcu, Eva Bezak & Kathleen Hintenlang
Moderator: Loredana Marcu

Title 1: In vitro development of MUC1-CE targeted alpha therapy for pancreatic ductal adenocarcinoma

Speaker: Ashleigh Hull
Allied Health and Human Performance Academic Unit, University of South Australia, Adelaide, SA, Australia.
Department of Nuclear Medicine, PET and Bone Densitometry, SA Medical Imaging, Royal Adelaide Hospital, Adelaide, SA, Australia.

Ashleigh Hull is a lecturer in Nuclear Medicine and PhD candidate (under submission) at the University of South Australia. Ashleigh’s research focuses on the development and characterisation of novel radioimmunoconjugates for the diagnosis and treatment of cancer. Her PhD project has led to the development of two novel therapeutic radioimmunoconjugates capable of treating pancreatic cancer at an in vitro level.  In addition to her academic and research roles, Ashleigh also maintains her clinical practice as a registered nuclear medicine technologist at SA Medical Imaging.


Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive malignancy and a leading cause of cancer-related death worldwide. Development of targeted therapies, such as a targeted alpha therapy (TAT), may improve outcomes of patients diagnosed with PDAC. In this study, a novel alpha-emitting radioimmunoconjugate, 225Ac-DOTA-C595, was developed to target PDAC by binding to cancer-specific mucin 1 epitopes (MUC1-CE). MUC1-CE is known to be overexpressed on over 90% of PDAC tissues yet has minimal expression on normal and benign tissues, offering an ideal expression profile for TAT purposes. A series of in vitro assays were performed to evaluate cell binding, internalisation and cytotoxicity of 225Ac-DOTA-C595 and establish the feasibility of using 225Ac-DOTA-C595 as a radioimmunoconjugate for the treatment of PDAC.

Title 2: Exploring Ultra-high Dose Rate Radiation and Growing as an Educator in Medical Physicist

Speaker: Ashley Cetnar, PhD, Assistant Professor Radiation Oncology

Ashley Cetnar is an Assistant Professor in the Department of Radiation Oncology at The Ohio State University. She is trained as both a clinical medical physicist and expert in teaching and learning. Within the clinic, she strives to provide excellent patient care in her role as a medical physicist by solving problems, applying science and technology, upholding quality and safety, and promoting innovation for new ways of treating patients. As an educator, she is passionate about helping others learn and grow as both individuals and within a team.


In this presentation, Dr. Cetnar will share her journey of involvement of research in ultra-high dose rate radiation therapy and journey professionally growing as an educator. From a research perspective, The Ohio State University currently has two ultra-high dose rate generating devices that can be used to deliver electrons with the next expected expansion to protons soon with the opening the new of proton therapy facility. This will include background information about FLASH, commissioning of new technology, exploration of dosimetry methods, and biological experiments. Dr. Cetnar has always been passionate about education and will share her pathway to completing a PhD in Education, educational programs, and medical physics education research.

Title 3: Making progress only needs to get started

Speaker: Leticia Irazola Rosales, Medical Physics at Centro de Investigaciones Biomédicas de la Rioja

Leticia Irazola is a Medical Physics from Spain. She made her studies in Physics at the University of Zaragoza (Spain) and then dedcated to the Medical Physics field with her MSc in Medical Physics at the University of Rennes I and the Centre Eugène Marquis (France), PhD thesis at the University of Sevilla (Spain) and PostDoc at the Pontificia Universidad Católica de Chile, Santiago de Chile (Chile).

Then she moved into the clinical field by performing the Medical Physics residency at the Clinica Universidad de Navarra (Spain). Based in La Rioja (Spain), she works now as a medical physicist combining her job as a Medical Physicist  with university teaching and research at the Centro de Investigaciones Biomédicas de La Rioja.

She is currently secretary of the Communications and Publications Committee, Secretary of the Spanish Early Career group of the SEFM and Chair of the Early Career SIG of the EFOMP.


I have never in my youthfulness imagined that I would became the Secretary or Chair of any scientific group.

When I was studying my University Degree I just thought which would my future become by studing such a “theoretical” career as Physics. During my 2nd year at University I assisted to a talk related to the Medical Physics profession and I realized then that it was the path I wanted to follow, I felt it was just puting my humble knowledge of physics to the service of public health.

Since then I can almost say that all my life has been by chance and made by choice. What I have clear at this point is that it is not only a matter of being the best at doing something but loving what you do and being passionate about it. This is the way best things come to you and dreams become reality.

Past Webinars 2024

24 January 2024 at 12 pm GMT; Duration 1 hour

View Recording

1 CPD/CME point is applied to this event. 

Organizer: Eva Bezak
Moderator: Eva Bezak

Title: From Pixels to Patients: The Influence of Gaming and Smartphone Developments on Radiation Oncology

Speaker: Dr Michael Douglass, Royal Adelaide Hospital, Adelaide, Australia

Dr. Michael Douglass is a principal medical physicist at the Royal Adelaide Hospital where he oversees treatment planning systems and planning support services. He also works part-time at the Australian Bragg Centre for Proton Therapy and Research where he contributes to proton therapy comparative planning and research. In addition, Dr. Douglass holds an academic role at the University of Adelaide, supervising Ph.D. and master’s student research. His expertise spans across a multitude of research areas, including proton therapy, Monte Carlo simulations, machine learning and 3D printing in radiation oncology, which is reflected in his 40+ peer-reviewed publications. Dr. Douglass’s notable contributions to the field have earned him multiple awards such as the 2021 Simpson Prize for Cancer Research and the 2021 ACPSEM Boyce Worthley Young Achiever Award.


In this presentation, we will explore how advancements in various industries, including the movie, video game, and smartphone industries, have contributed to the progress of radiation oncology. We will discuss how developments such as visual effects in the movie industry have paved the way for the creation of synthetic training data for machine learning models in radiation oncology. Additionally, we will examine how the smartphone industry has enabled new methods of 3D scanning patients for treatments like TBI, TSET, Brachytherapy, and 3D printed bolus, thanks to technologies like Gaussian platting, NERF, LiDAR, and iPhone capabilities. The integration of augmented reality in the video game industry has revolutionized the visualization of medical imaging data, providing volumetric views and assisting in breath hold coaching. We will also explore the impact of GPU technology on deep learning segmentation, auto planning, and accelerated dose calculations, as well as the potential of large language models like Llama 2 and GPT in education and automated patient record transcription. Through these examples, we will highlight the interconnectedness of these industries with radiation oncology and the ongoing advancements they bring to the field.

Learning Objectives:

  1. Gain an understanding of the advancements in optical scanning technologies, including LiDAR, photogrammetry, and NERF, and their applications in radiation oncology.
  2. Understand how consumer technologies, such as smartphones and gaming, have contributed to the progress of radiation oncology and medicine as a whole.
  3. Learn about the benefits and potential applications of large language models, like Llama 2 and GPT, in radiation oncology, including education and automated patient record transcription.
  4. Examine the integration of visual effects in the movie industry and its influence on the creation of synthetic training data for machine learning models in radiation oncology.
  5. Understand the impact of augmented reality in the video game industry on the visualization of medical imaging data and its role in assisting in breath hold coaching.